107 related articles for article (PubMed ID: 17258135)
1. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
Ng WH; Wan GQ; Too HP
J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
Yang JJ; Yin JH; Yang DI
Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
Kuo YC; Liang CT
Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
[TBL] [Abstract][Full Text] [Related]
8. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Hoshino T; Barker M; Deen DF
Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
Kang MK; Kang SK
Biochem Biophys Res Commun; 2008 Sep; 373(4):539-44. PubMed ID: 18590702
[TBL] [Abstract][Full Text] [Related]
11. S-nitrosoglutathione and hypoxia-inducible factor-1 confer chemoresistance against carbamoylating cytotoxicity of BCNU in rat C6 glioma cells.
Yang DI; Chen SD; Yin JH; Hsu CY
Ann N Y Acad Sci; 2005 May; 1042():229-34. PubMed ID: 15965067
[TBL] [Abstract][Full Text] [Related]
12. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
[TBL] [Abstract][Full Text] [Related]
14. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line.
Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M
Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17.
Liang BC; Ullyatt E
Clin Cancer Res; 1998 Mar; 4(3):773-81. PubMed ID: 9533547
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
[TBL] [Abstract][Full Text] [Related]
20. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
Sliwa M; Markovic D; Gabrusiewicz K; Synowitz M; Glass R; Zawadzka M; Wesolowska A; Kettenmann H; Kaminska B
Brain; 2007 Feb; 130(Pt 2):476-89. PubMed ID: 17107968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
